Hautarztpraxis Dr. Leitz & Kollegen

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Psoriasis1 trial
• Vitiligo1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed4 trials

Lead sponsor

• Amgen1 trial
• Amgen Inc.1 trial
• Arctic Bioscience AS1 trial
• Pfizer1 trial

Closed trials

• Completed

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· Phase 3· Amgen Inc.· Source

• Completed

  An efficacy and safety study of HRO350 in patients with mild-to-moderate psoriasis (the ‘HeROPA’ study)

  2022-501850-12-00· Phase 2· Arctic Bioscience AS· Source

• Completed

  A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo

  NCT05583526· Phase 3· Pfizer· Source

• Completed

  A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

  NCT05398445· Phase 3· Amgen· Source